TRIM48

gene
On this page

Also known as RNF101

Summary

TRIM48 (tripartite motif containing 48, HGNC:19021) is a protein-coding gene on chromosome 11q11, encoding E3 ubiquitin-protein ligase TRIM48 (Q8IWZ4). E3 ubiquitin-protein ligase which promotes K48-linked polyubiquitination of protein methyltransferase PRMT1, leading to PRMT1 degradation.

Predicted to enable ubiquitin protein ligase activity. Predicted to be involved in innate immune response and regulation of gene expression. Located in cytosol.

Source: NCBI Gene 79097 — RefSeq curated summary.

At a glance

  • GWAS associations: 11
  • Clinical variants (ClinVar): 54 total
  • MANE Select transcript: NM_024114

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:19021
Approved symbolTRIM48
Nametripartite motif containing 48
Location11q11
Locus typegene with protein product
StatusApproved
AliasesRNF101
Ensembl geneENSG00000150244
Ensembl biotypeprotein_coding
Entrez79097

Gene structure

Transcript identifiers

Ensembl transcripts: 1 — 1 protein_coding

ENST00000417545

RefSeq mRNA: 1 — MANE Select: NM_024114 NM_024114

CCDS: CCDS7947

Canonical transcript exons

ENST00000417545 — 6 exons

ExonStartEnd
ENSE000022106065526215555262311
ENSE000024393815526490055265314
ENSE000024584595526835055268372
ENSE000024671485526924255269339
ENSE000024905985527043755271114
ENSE000025134385526560055265695

Expression profiles

Bgee: expression breadth tissue_specific, 3 present calls, max score 37.20.

FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0139 / max 18.1310, expressed in 3 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
1142460.01393

Top tissues by expression

131 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
colonic epitheliumUBERON:000039737.20gold quality
sural nerveUBERON:001548836.58gold quality
ventricular zoneUBERON:000305336.48gold quality
cortical plateUBERON:000534336.47gold quality
apex of heartUBERON:000209836.26gold quality
bone marrow cellCL:000209236.16gold quality
ganglionic eminenceUBERON:000402335.49gold quality
skeletal muscle tissueUBERON:000113433.38gold quality
muscle tissueUBERON:000238532.41gold quality
hindlimb stylopod muscleUBERON:000425232.15gold quality
bone marrowUBERON:000237131.74gold quality
stromal cell of endometriumCL:000225529.87gold quality
prefrontal cortexUBERON:000045129.21gold quality
skin of legUBERON:000151128.73gold quality
smooth muscle tissueUBERON:000113528.60silver quality
duodenumUBERON:000211428.14gold quality
liverUBERON:000210728.04gold quality
urinary bladderUBERON:000125527.70gold quality
lymph nodeUBERON:000002927.57gold quality
tonsilUBERON:000237227.05gold quality
islet of LangerhansUBERON:000000626.55gold quality
vermiform appendixUBERON:000115426.42gold quality
leukocyteCL:000073826.15gold quality
monocyteCL:000057626.00gold quality
bloodUBERON:000017826.00gold quality
gall bladderUBERON:000211025.98gold quality
olfactory segment of nasal mucosaUBERON:000538625.89gold quality
placentaUBERON:000198725.81gold quality
zone of skinUBERON:000001425.79gold quality
muscle of legUBERON:000138325.12gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes3.28

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

52 targeting TRIM48, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-188-3P100.0068.761240
HSA-MIR-4776-3P100.0068.731340
HSA-MIR-6825-5P99.9669.813431
HSA-MIR-314399.9371.963104
HSA-MIR-6499-3P99.9066.381212
HSA-MIR-124-3P99.8973.743043
HSA-MIR-506-3P99.8973.553057
HSA-MIR-6875-3P99.8270.262983
HSA-MIR-204-5P99.7971.622439
HSA-MIR-211-5P99.7971.652440
HSA-MIR-3150A-3P99.7664.441640
HSA-MIR-6763-5P99.7664.681767
HSA-MIR-10393-3P99.7266.56961
HSA-MIR-6801-5P99.7266.50981
HSA-MIR-80299.6167.701254
HSA-MIR-6861-3P99.6068.46444
HSA-MIR-4762-5P99.5768.541424
HSA-MIR-1252-3P99.5567.712862
HSA-MIR-105-5P99.5469.242060
HSA-MIR-7853-5P99.5469.302055
HSA-MIR-122B-5P99.4670.811457
HSA-MIR-4762-3P99.4369.722363
HSA-MIR-3678-3P99.3167.101432
HSA-MIR-593-3P99.2267.281327
HSA-MIR-361-3P99.1966.451381
HSA-MIR-10399-5P99.1769.872610
HSA-MIR-6504-3P99.1769.312891
HSA-MIR-478499.1567.411733
HSA-MIR-323B-3P99.1468.89725
HSA-MIR-7854-3P99.0866.261117

Literature-anchored findings (GeneRIF, showing 1)

  • TRIM48 Promotes ASK1 Activation and Cell Death through Ubiquitination-Dependent Degradation of the ASK1-Negative Regulator PRMT1 (PMID:29186683)

Cross-species orthologs

0 orthologs

Paralogs (80): MID2 (ENSG00000080561), TRIM9 (ENSG00000100505), MID1 (ENSG00000101871), MEFV (ENSG00000103313), TRIM35 (ENSG00000104228), TRIM14 (ENSG00000106785), TRIM37 (ENSG00000108395), TRIM2 (ENSG00000109654), TRIM3 (ENSG00000110171), TRIM38 (ENSG00000112343), TRIM62 (ENSG00000116525), TRIM67 (ENSG00000119283), TRIM32 (ENSG00000119401), BSPRY (ENSG00000119411), TRIM25 (ENSG00000121060), TRIM6 (ENSG00000121236), TRIM24 (ENSG00000122779), TRIM51 (ENSG00000124900), TRIM28 (ENSG00000130726), TRIM21 (ENSG00000132109), TRIM5 (ENSG00000132256), TRIM22 (ENSG00000132274), TRIM47 (ENSG00000132481), TRIM45 (ENSG00000134253), TRIM29 (ENSG00000137699), TRIM54 (ENSG00000138100), PML (ENSG00000140464), TRIM65 (ENSG00000141569), TRIM43B (ENSG00000144010), TRIM43 (ENSG00000144015), TRIM7 (ENSG00000146054), TRIM41 (ENSG00000146063), TRIM50 (ENSG00000146755), TRIM4 (ENSG00000146833), TRIM55 (ENSG00000147573), TRIM36 (ENSG00000152503), TRIM11 (ENSG00000154370), TRIM74 (ENSG00000155428), TRIM42 (ENSG00000155890), TRIM63 (ENSG00000158022)

Protein

Protein identifiers

E3 ubiquitin-protein ligase TRIM48Q8IWZ4 (reviewed: Q8IWZ4)

Alternative names: RING finger protein 101, Tripartite motif-containing protein 48

All UniProt accessions (1): Q8IWZ4

UniProt curated annotations — full annotation on UniProt →

Function. E3 ubiquitin-protein ligase which promotes K48-linked polyubiquitination of protein methyltransferase PRMT1, leading to PRMT1 degradation. This suppresses methylation of the PRMT1 substrate MAP3K5/ASK1, promoting its activation and increasing MAP3K5-dependent cell death induced by oxidative stress. TRIM48-mediated ubiquitination of PRMT1 also suppresses methylation of FOXO1 by PRMT1, leading to inhibition of FOXO1 transcriptional activity. Additionally, it inhibits RIG-I-mediated antiviral signaling, functioning as an inducible negative feedback regulator of this pathway.

Subunit / interactions. Interacts with PRMT1; the interaction leads to ubiquitination of PRMT1 by TRIM48. Interacts with MAP3K5. Interacts with STRAP.

Subcellular location. Cytoplasm. Cytosol.

Induction. Upon RIG-I/DDX58 stimulation.

Similarity. Belongs to the TRIM/RBCC family.

RefSeq proteins (1): NP_077019* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000315Znf_B-boxDomain
IPR001841Znf_RINGDomain
IPR013083Znf_RING/FYVE/PHDHomologous_superfamily
IPR050143TRIM/RBCCFamily

Pfam: PF00643, PF15227

UniProt features (8 total): binding site 4, zinc finger region 2, chain 1, mutagenesis site 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8IWZ4-F181.330.37

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Ligand- & substrate-binding residues (4): 109; 112; 131; 137

Mutagenesis-validated functional residues (1):

PositionPhenotype
46abolishes prmt1 ubiquitination and map3k5 activation.

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-877300Interferon gamma signaling

MSigDB gene sets: 50 (showing top): REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM, MODULE_255, GOBP_MACROMOLECULE_CATABOLIC_PROCESS, MODULE_317, IVANOVA_HEMATOPOIESIS_MATURE_CELL, GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM, GOBP_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS, GOBP_PROTEIN_CATABOLIC_PROCESS, MODULE_69, GOBP_PROTEOLYSIS, GOMF_ACYLTRANSFERASE_ACTIVITY, GOMF_AMINOACYLTRANSFERASE_ACTIVITY, GOMF_UBIQUITIN_LIKE_PROTEIN_LIGASE_ACTIVITY, MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP, KRAS.600_UP.V1_DN

GO Biological Process (3): regulation of gene expression (GO:0010468), proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161), innate immune response (GO:0045087)

GO Molecular Function (5): zinc ion binding (GO:0008270), ubiquitin protein ligase activity (GO:0061630), protein binding (GO:0005515), transferase activity (GO:0016740), metal ion binding (GO:0046872)

GO Cellular Component (2): cytoplasm (GO:0005737), cytosol (GO:0005829)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
Interferon Signaling1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure2
gene expression1
regulation of macromolecule biosynthetic process1
ubiquitin-dependent protein catabolic process1
proteasomal protein catabolic process1
immune response1
defense response to symbiont1
transition metal ion binding1
ubiquitin-protein transferase activity1
ubiquitin-like protein ligase activity1
binding1
catalytic activity1
cation binding1
intracellular anatomical structure1
cytoplasm1

Protein interactions and networks

STRING

338 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
TRIM48PRAMEF13Q5VWM6505
TRIM48OR8J3Q8NGG0505
TRIM48PRAMEF1O95521480
TRIM48PRAMEF11O60813480
TRIM48KHDC1LQ5JSQ8479
TRIM48OR5F1O95221476
TRIM48RFPL2O75678471
TRIM48OR5D16Q8NGK9469
TRIM48OR4A15Q8NGL6448
TRIM48OR8I2Q8N0Y5447
TRIM48OR5T2Q8NGG2447
TRIM48OR5D14Q8NGL3447
TRIM48OR8H2Q8N162447
TRIM48KBTBD3Q8NAB2445
TRIM48OR5AS1Q8N127436

IntAct

4 interactions, top by confidence:

ABTypeScore
TRIM48NME7psi-mi:“MI:0915”(physical association)0.560
NME7TRIM48psi-mi:“MI:0915”(physical association)0.000

BioGRID (5): PRMT1 (Affinity Capture-Western), PRMT1 (Biochemical Activity), TRIM48 (Two-hybrid), TRIM48 (Co-localization), TRIM48 (Affinity Capture-Western)

ESM2 similar proteins: A0A3B3IT33, A6NCK2, A6NDI0, A6NGJ6, A6NI03, A6NLI5, C9J1S8, I1YAP6, K7N6K2, P0CI25, P0CI26, P86449, Q0PF16, Q1ACD5, Q1ACD6, Q1ACD7, Q1ACD8, Q2YEM8, Q2YEM9, Q2YEN0, Q2YEN2, Q3ZEE5, Q587N6, Q587N7, Q5BN31, Q5C8T6, Q5C8T8, Q5C8U1, Q5C8U3, Q5C8U4, Q5D7H7, Q5D7H8, Q5D7I0, Q5D7I1, Q5D7I2, Q5D7I3, Q5D7I5, Q5D7I6, Q5D7I9, Q5D7J0

Diamond homologs: A0A3B3IT33, A6NCK2, A6NDI0, A6NGJ6, A6NI03, A6NLI5, B0BLU1, C9J1S8, I1YAP6, O00478, O00481, O15344, O75677, O75678, O75679, O76064, P0CI25, P0CI26, P18892, P19474, P62603, P86448, P86449, Q13410, Q2HJ46, Q3C1V9, Q3TL54, Q4KLN8, Q5EBN2, Q5PQN2, Q5R4I2, Q5R996, Q61510, Q62556, Q6INS5, Q6MFY8, Q6UX41, Q6UXE8, Q6ZWI9, Q7T308

SIGNOR signaling

1 interactions.

AEffectBMechanism
Ub:E2“up-regulates activity”TRIM48ubiquitination

Disease & clinical

Clinical variants and AI predictions

ClinVar

54 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance51
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

710 predictions. Top by Δscore:

VariantEffectΔscore
11:55262308:AGCGG:Adonor_loss1.0000
11:55262309:GCG:Gdonor_gain1.0000
11:55262310:CGGT:Cdonor_loss1.0000
11:55262312:G:GGdonor_gain1.0000
11:55268344:TTACA:Tacceptor_loss1.0000
11:55268345:TACA:Tacceptor_loss1.0000
11:55268346:ACAGG:Aacceptor_loss1.0000
11:55268347:CAGGC:Cacceptor_loss1.0000
11:55268348:A:ACacceptor_loss1.0000
11:55268348:A:AGacceptor_gain1.0000
11:55268349:G:GAacceptor_gain1.0000
11:55268349:G:Tacceptor_loss1.0000
11:55268373:G:GAdonor_loss1.0000
11:55268373:G:GGdonor_gain1.0000
11:55268374:T:Adonor_loss1.0000
11:55269238:GCA:Gacceptor_loss1.0000
11:55269240:A:AGacceptor_gain1.0000
11:55269240:A:ATacceptor_loss1.0000
11:55269241:G:GAacceptor_gain1.0000
11:55269241:GGA:Gacceptor_gain1.0000
11:55269241:GGAGT:Gacceptor_gain1.0000
11:55269336:TGAGG:Tdonor_loss1.0000
11:55269337:GAG:Gdonor_gain1.0000
11:55269338:AG:Adonor_gain1.0000
11:55269338:AGG:Adonor_loss1.0000
11:55269339:GG:Gdonor_gain1.0000
11:55269340:G:GGdonor_gain1.0000
11:55269341:T:Gdonor_loss1.0000
11:55270435:A:AGacceptor_gain1.0000
11:55270435:AGT:Aacceptor_gain1.0000

AlphaMissense

1499 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000011305 (11:55266266 A>C,G,T), RS1000131100 (11:55263435 T>C), RS1000160530 (11:55263576 C>T), RS1000334849 (11:55268410 C>G,T), RS1000487384 (11:55262857 A>T), RS1000612077 (11:55267653 T>A,C,G), RS1000687004 (11:55268650 G>A), RS1000767392 (11:55271487 T>A), RS1001291713 (11:55269689 T>C), RS1001742986 (11:55269463 A>G), RS1002903231 (11:55260827 C>G,T), RS1003500198 (11:55261682 C>T), RS1003506443 (11:55266000 TG>T), RS1003609812 (11:55265399 A>C,T), RS1003681643 (11:55270363 T>C,G)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

11 associations (top):

StudyTraitp-value
GCST005580_137Intraocular pressure7.000000e-13
GCST006624_128Systolic blood pressure1.000000e-16
GCST006947_12Feeling fed-up2.000000e-09
GCST008163_606Height8.000000e-06
GCST009733_166Urinary metabolite levels in chronic kidney disease1.000000e-73
GCST010241_199Apolipoprotein A1 levels4.000000e-25
GCST010242_531HDL cholesterol levels7.000000e-47
GCST010244_112Triglyceride levels8.000000e-09
GCST012020_180Serum metabolite levels7.000000e-55
GCST012020_208Serum metabolite levels2.000000e-50
GCST012021_105Serum metabolite levels7.000000e-55

EFO canonical traits (7, from GWAS)

EFO IDTrait name
EFO:0004695intraocular pressure measurement
EFO:0006335systolic blood pressure
EFO:0009588feeling “fed-up” measurement
EFO:0005116urinary metabolite measurement
EFO:0004614apolipoprotein A 1 measurement
EFO:0004612high density lipoprotein cholesterol measurement
EFO:0004530triglyceride measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

7 total (human), top 7 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyrenedecreases methylation, decreases expression2
perfluorooctanoic aciddecreases expression1
Acetaminophendecreases expression1
Calcitriolincreases expression, affects cotreatment1
Malathiondecreases expression1
Dihydrotestosteroneincreases expression1
Testosteroneaffects cotreatment, increases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.